Partnering with patients on clinical trials

Location: Virtual Event

Date:

Event description:

Join us for the Novotech-sponsored panel discussion Partnering with patients on clinical trials as part of Endpoints Clinical Trials Day 2024. 

 

Patients are often an overlooked consideration in clinical trial design, leading to costly delays that can disrupt timelines and derail progress. This expert-led panel will explore best practices for incorporating patient feedback to accelerate recruitment, engage patients directly in trial design, and foster meaningful collaboration to ensure trial success. 

 

Speakers: 

  • Scott Schliebner, VP, Drug Development Consulting, Novotech 
  • Melody Burchett, President, A Cure in Sight 
  • Dr. Layla Hosseini-Gerami, Chief Data Science Officer, Ignota Labs 
  • Ken Getz, Executive Director, Research Professor (PHCM), Tufts Center for the Study of Drug Development. 
  • John Carroll, Founder & Editor, Endpoints News (Moderator) 

Register here

This event has concluded

Thank you for your interest in Novotech at this event. While the event has ended, our experts continue to support sponsors across all stages of clinical development.

Have a question or want to continue the conversation?

Talk to a Clinical Development Expert

Meet Our Team

Novotech

Scott Schliebner

Novotech
Vice President - Drug Development Consulting

Plus experts from our China, Drug Development, and global Commercial teams.